Markets

News Details

( 07 Nov 2017)
Alembic Pharmaceutic - Outcome of Board Meeting

With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended on 30th September, 2017.

We enclose herewith the following:

a) Consolidated Unaudited Financial Results for the quarter and half year ended on 30th September, 2017 and Consolidated Statement of Assets and Liabilities as at 30th September, 2017.
b) Standalone Unaudited Financial Results for the quarter and half year ended on 30th September, 2017 and Standalone Statement of Assets and Liabilities as at 30th September, 2017.
c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.
d) Press Release.
e) Investor Presentation.

The time of commencement of the Board Meeting was 10:30 a.m. and the time of conclusion was 12:15 p.m.

We request you to kindly take the same on record.